371 related articles for article (PubMed ID: 25873825)
1. Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place.
Gupta A; Subzposh F; Hankins SR; Kutalek SP
Tex Heart Inst J; 2015 Apr; 42(2):140-3. PubMed ID: 25873825
[TBL] [Abstract][Full Text] [Related]
2. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
Ishida Y; Payne JE; Field ME; Gold MR
J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy.
Pecha S; Wilke I; Bernhardt A; Hakmi S; Yildirim Y; Steven D; Reichenspurner H; Willems S; Deuse T; Aydin A
J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1109-14. PubMed ID: 24862733
[TBL] [Abstract][Full Text] [Related]
4. Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infection.
Eulert-Grehn JJ; Sterner I; Schoenrath F; Stein J; Mulzer J; Kurz S; Lanmüller P; Barthel F; Unbehaun A; Klein C; Jacobs S; Falk V; Potapov E; Starck C
J Heart Lung Transplant; 2022 Jun; 41(6):810-817. PubMed ID: 35422347
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review.
Black-Maier E; Lewis RK; Barnett AS; Pokorney SD; Sun AY; Koontz JI; Daubert JP; Piccini JP
Heart Rhythm; 2020 Sep; 17(9):1536-1544. PubMed ID: 32304733
[TBL] [Abstract][Full Text] [Related]
7. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing.
Poole JE; Gold MR
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599
[No Abstract] [Full Text] [Related]
8. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation.
Thomas IC; Cork DP; Levy A; Nayak H; Beshai JF; Burke MC; Moss JD
Pacing Clin Electrophysiol; 2014 Apr; 37(4):464-72. PubMed ID: 24237034
[TBL] [Abstract][Full Text] [Related]
9. Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications.
Alvarez PA; Sperry BW; Pérez AL; Yaranov DM; Randhawa V; Luthman J; Cantillon DJ; Starling RC
J Am Heart Assoc; 2019 Jul; 8(14):e011813. PubMed ID: 31280637
[TBL] [Abstract][Full Text] [Related]
10. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
[TBL] [Abstract][Full Text] [Related]
11. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device.
Labedi MR; Alharethi R; Kfoury AG; Budge D; Bruce R; Rasmusson B; Bunch TJ
ASAIO J; 2013; 59(2):136-9. PubMed ID: 23438775
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
Migliore F; Schiavone M; Pittorru R; Forleo GB; De Lazzari M; Mitacchione G; Biffi M; Gulletta S; Kuschyk J; Dall'Aglio PB; Rovaris G; Tilz R; Mastro FR; Iliceto S; Tondo C; Di Biase L; Gasperetti A; Tarzia V; Gerosa G
Int J Cardiol; 2024 Apr; 400():131807. PubMed ID: 38272130
[TBL] [Abstract][Full Text] [Related]
13. Electromagnetic interference from left ventricular assist device in patients with transvenous implantable cardioverter-defibrillator.
Khetarpal BK; Lee JZ; Javaid AI; Mi L; Venepally NR; Narasimhan B; Hardaway BW; Cha YM; Kusumoto F; Mulpuru SK; Srivathsan K
Pacing Clin Electrophysiol; 2021 Jul; 44(7):1163-1175. PubMed ID: 33977542
[TBL] [Abstract][Full Text] [Related]
14. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients.
Oswald H; Schultz-Wildelau C; Gardiwal A; Lüsebrink U; König T; Meyer A; Duncker D; Pichlmaier MA; Klein G; Strüber M
Eur J Heart Fail; 2010 Jun; 12(6):593-9. PubMed ID: 20406799
[TBL] [Abstract][Full Text] [Related]
15. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review.
López-Gil M; Fontenla A; Delgado JF; Rodríguez-Muñoz D
Eur Heart J Case Rep; 2019 Jun; 3(2):. PubMed ID: 31449611
[TBL] [Abstract][Full Text] [Related]
17. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
18. Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients.
Rorris FP; Charitos C
Heart Fail Rev; 2021 Jul; 26(4):763-765. PubMed ID: 33404997
[TBL] [Abstract][Full Text] [Related]
19. Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.
Galand V; Flécher E; Auffret V; Boulé S; Vincentelli A; Dambrin C; Mondoly P; Sacher F; Nubret K; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Verdonk C; Ghodbane W; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Radu C; Pierre B; Bourguignon T; Eschalier R; D'Ostrevy N; Bories MC; Marijon E; Vanhuyse F; Blangy H; Verhoye JP; Leclercq C; Martins RP;
JACC Clin Electrophysiol; 2018 Sep; 4(9):1166-1175. PubMed ID: 30236390
[TBL] [Abstract][Full Text] [Related]
20. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator.
Matthews JC; Betley D; Morady F; Pelosi F
J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1107-8. PubMed ID: 17403078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
